Inhibitory effect of ramosetron on corticotropin releasing factor‐ and soybean oil‐induced delays in gastric emptying in rats
暂无分享,去创建一个
N. Seki | M. Yamano | Y. Keto | T. Sengoku | T. Hirata | T. Yokoyama
[1] M. Takei,et al. Acotiamide hydrochloride (Z-338) enhances gastric motility and emptying by inhibiting acetylcholinesterase activity in rats. , 2011, European journal of pharmacology.
[2] P. Bertrand,et al. Serotonin release and uptake in the gastrointestinal tract , 2010, Autonomic Neuroscience.
[3] H. Miwa,et al. Analysis of the Gastrointestinal Symptoms of Uninvestigated Dyspepsia and Irritable Bowel Syndrome , 2009, Gut and liver.
[4] K. Nozawa,et al. TRPA1 agonists delay gastric emptying in rats through serotonergic pathways , 2009, Naunyn-Schmiedeberg's Archives of Pharmacology.
[5] W. Chey,et al. An Evidence-Based Position Statement on the Management of Irritable Bowel Syndrome , 2008, The American Journal of Gastroenterology.
[6] M. Sasamata,et al. Effects of serotonin 5-HT(3) receptor antagonists on CRF-induced abnormal colonic water transport and defecation in rats. , 2008, European journal of pharmacology.
[7] M. Sasamata,et al. Effects of serotonin 5‐HT3 receptor antagonists on stress‐induced colonic hyperalgesia and diarrhoea in rats: a comparative study with opioid receptor agonists, a muscarinic receptor antagonist and a synthetic polymer , 2008, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[8] A. Nishida,et al. The effect of paroxetine on the pharmacokinetics, safety, and tolerability of ramosetron in healthy subjects , 2008, European Journal of Clinical Pharmacology.
[9] M. Hongo,et al. A randomized, double-blind, placebo-controlled clinical trial of the effectiveness of the novel serotonin type 3 receptor antagonist ramosetron in both male and female Japanese patients with diarrhea-predominant irritable bowel syndrome , 2008, Scandinavian journal of gastroenterology.
[10] M. Sasamata,et al. Inhibitory effects of ramosetron, a potent and selective 5-HT3-receptor antagonist, on conditioned fear stress-induced abnormal defecation and normal defecation in rats: comparative studies with antidiarrheal and spasmolytic agents. , 2008, Journal of pharmacological sciences.
[11] Lin Chang,et al. FUNCTIONAL BOWEL DISORDERS , 2018, The American Journal of Gastroenterology.
[12] D. Savastano,et al. Intestinal nutrients elicit satiation through concomitant activation of CCK1 and 5-HT3 receptors , 2007, Physiology & Behavior.
[13] M. Sasamata,et al. Evaluation of the pharmacological profile of ramosetron, a novel therapeutic agent for irritable bowel syndrome. , 2007, Journal of pharmacological sciences.
[14] E. Lindström,et al. Functional CRF receptors in BON cells stimulate serotonin release. , 2007, Biochemical pharmacology.
[15] M. R. Hayes,et al. Serotonin-type 3 receptors mediate intestinal lipid-induced satiation and Fos-like immunoreactivity in the dorsal hindbrain. , 2007, American journal of physiology. Regulatory, integrative and comparative physiology.
[16] T. Dinan,et al. Functional dyspepsia: are psychosocial factors of relevance? , 2006, World journal of gastroenterology.
[17] J. Tack,et al. Impact of Coexisting Irritable Bowel Syndrome on Symptoms and Pathophysiological Mechanisms in Functional Dyspepsia , 2004, American Journal of Gastroenterology.
[18] Y. Taché,et al. CRF1 receptor signaling pathways are involved in stress‐related alterations of colonic function and viscerosensitivity: implications for irritable bowel syndrome , 2004, British journal of pharmacology.
[19] M. Crowell,et al. Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea , 2003, American Journal of Gastroenterology.
[20] T. Tsuruo,et al. Contribution of P‐glycoprotein to efflux of ramosetron, a 5‐HT3 receptor antagonist, across the blood‐brain barrier , 2002, The Journal of pharmacy and pharmacology.
[21] N. Read,et al. Food and hypersensitivity in functional dyspepsia , 2002, Gut.
[22] M. A. Gülpınar,et al. Enterogastric Brake In Rats With Segmental Bowel Resection: Role Of Capsaicin‐Sensitive Nerves , 2002, Clinical and experimental pharmacology & physiology.
[23] M. Camilleri,et al. Functional gastroduodenal disorders , 1999, Gut.
[24] I. Hirotsu,et al. Affinity profiles of various muscarinic antagonists for cloned human muscarinic acetylcholine receptor (mAChR) subtypes and mAChRs in rat heart and submandibular gland. , 1999, Life sciences.
[25] H. Raybould,et al. PYY immunoneutralization does not alter lipid-induced inhibition of gastric emptying in rats , 1999, Regulatory Peptides.
[26] B. Schneeman,et al. Cholecystokinin and serotonin receptors in the regulation of fat-induced satiety in rats. , 1999, American journal of physiology. Regulatory, integrative and comparative physiology.
[27] S. Fukudo,et al. Involvement of the 5-HT3 receptor in CRH-induce defecation in rats. , 1998, The American journal of physiology.
[28] S. Akuzawa,et al. Effect of serotonin (5-HT)3-receptor antagonists YM060, YM114 (KAE-393), ondansetron and granisetron on 5-HT4 receptors and gastric emptying in rodents. , 1995, Japanese Journal of Pharmacology.
[29] S. Higuchi,et al. Metabolic Fate of Ramosetron Hydrochloride (2): Absorption, Distribution and Excretion after Oral Administration of 14C-Ramosetron Hydrochloride to Rats , 1995 .
[30] K. Mousavizadeh,et al. Effects of atropine, pirenzepine, clonidine, and morphine on biphasic response of rat gastric fundus to field stimulation. , 1994, General Pharmacology.
[31] A. Megens,et al. Loperamide. Survey of studies on mechanism of its antidiarrheal activity. , 1993, Digestive diseases and sciences.
[32] S. Harasawa. Effect of itopride hydrochloride on gastric emptying in chronic gastritis patients , 1993 .
[33] Y. Taché,et al. Central nervous system action of corticotropin-releasing factor to inhibit gastric emptying in rats. , 1987, The American journal of physiology.
[34] J. Junien,et al. Interactions of trimebutine with guinea‐pig opioid receptors , 1987, The Journal of pharmacy and pharmacology.